Programmed death-ligand 1 (PD-L1) Non-small Cell Lung Cancer (NSCLC): Overview, Epidemiology, Treatment Market, Emerging Drugs and Key players

PD-L1 (also known as CD274) is considered an immune checkpoint is facilitating anti-tumour suppression of the immune pathway. How has PD-L1 NSCLC impacted people's lives? Total cases of Programmed death-ligand 1 (PD-L1) mutated NSCLC in 7MM was 242,014 in 2017. Programmed death-ligand 1 (PD-L1) NSCLC cases in the United States in 2017 was 89,597. Programmed death-ligand 1 (PD-L1) NSCLC cases in ..

2020.08.21